Back to list
#46
Cipla Group – Caring Through Chemistry, Innovating Through Legacy
Key Person: Yusuf Khwaja Hameid
Yusuf Hameid turned Cipla into a life-saving brand during the HIV/AIDS crisis by challenging global drug pricing norms. The family’s commitment to access and affordability has earned Cipla global respect. Today, the next generation is innovating in respiratory care, biosimilars, and digital health, honouring a tradition where science meets social justice.
See more
Yusuf Hameid turned Cipla into a life-saving brand during the HIV/AIDS crisis by challenging global drug pricing norms. The family’s commitment to access and affordability has earned Cipla global respect. Today, the next generation is innovating in respiratory care, biosimilars, and digital health, honouring a tradition where science meets social justice.
See more
Yusuf Hameid turned Cipla into a life-saving brand during the HIV/AIDS crisis by challenging global drug pricing norms. The family’s commitment to access and affordability has earned Cipla global respect. Today, the next generation is innovating in respiratory care, biosimilars, and digital health, honouring a tradition where science meets social justice.
See more
Yusuf Hameid turned Cipla into a life-saving brand during the HIV/AIDS crisis by challenging global drug pricing norms. The family’s commitment to access and affordability has earned Cipla global respect. Today, the next generation is innovating in respiratory care, biosimilars, and digital health, honouring a tradition where science meets social justice.
See more
Yusuf Hameid turned Cipla into a life-saving brand during the HIV/AIDS crisis by challenging global drug pricing norms. The family’s commitment to access and affordability has earned Cipla global respect. Today, the next generation is innovating in respiratory care, biosimilars, and digital health, honouring a tradition where science meets social justice.
See more
Net Worth (INR)
₹39,278 Cr
Net Worth (USD)
$4,707 Mn
Location
London